Intrathecal Trastuzumab: Immunotherapy Improves the Prognosis of Leptomeningeal Metastases in HER-2+ Breast Cancer Patient

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-015-0084-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Complete Response in HER2+ Leptomeningeal Carcinomatosis From Breast Cancer With Intrathecal Trastuzumab

Breast Cancer Research and Treatment
Cancer ResearchOncology
2011English

HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2004English

Trastuzumab in Combination With Metronomic Cyclophosphamide and Methotrexate in Patients With HER-2 Positive Metastatic Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2006English

FEN1 Knockdown Improves Trastuzumab Sensitivity in Human Epidermal Growth Factor 2‑positive Breast Cancer Cells

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Pcn75 - Budget Impact Model of Subcutaneous Trastuzumab Compared With Intravenous Trastuzumab on the Treatment of Her-2 Positive Breast Cancer in the Brazilian Private Healthcare System

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PTEN Expression as a Predictor for the Response to Trastuzumab-Based Therapy in Her-2 Overexpressing Metastatic Breast Cancer

PLoS ONE
Multidisciplinary
2017English

Clinical Experience of Dual Targeted Blockade (Pertuzumab + Trastuzumab + Docetaxel) in Neoadjuvant Therapy of Early HER-2-Positive Breast Cancer

Effective Pharmacotherapy
2019English

Reduction in HER-2 Protein Expression in a Breast Tumor HER-2 Positive After Only One Injection of Trastuzumab: A Case Report

Cases Journal
2009English

Targeting HER-2 in Gastric Cancer &Ndash; Incorporation of Trastuzumab Into the Treatment of Operable Disease

Gastrointestinal Cancer: Targets and Therapy
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy